Mr. S.M. Mudda is the founding Managing Director of the company. Mr. Mr. Mudda is a successful pharmacy professional with over 40 years of experience in leading Indian multinational pharmaceutical companies present in India, the EU, and the USA and has held senior management positions as Director in technical and business functions.

2022年4月6日 · SM Mudda, MD, Misom Labs gave a Special Address at ADL Conclave 2022 on the theme of the event, “Preparing for an era of innovation”. He drew from his vast experience as a pharmacy professional with over 40 years experience in leading Indian multinational pharma companies present in India, the EU and the US to share a lot of insights which ...

Leadership, GMP, Sales and more. s.m Mudda has 3 emails and 3 mobile phone numbers on RocketReach. Looking for a different s.m Mudda? Find contact details for 700 million professionals. Get s.m Mudda's email address (s******@misomlabs.com) and phone number (+91 99720 2....) at RocketReach. Get 5 free searches.

2016年5月14日 · SM Mudda, Chairman, Regulatory Affairs Committee, IDMA, Mumbai examines where India’s pharma industry stands in terms of current expectations of the regulatory authorities and the state of GMP compliance in the sector. Achieving quality excellence seems an elusive goal for the pharmaceutical industry.

2022年4月6日 · The first panel discussion of PPL Conclave 2022 was on a very important topic, Fostering an ecosystem for pharma packaging… SM Mudda, MD, Misom Labs highlights that we have entered into an era of disruptive innovation and emphasises that those who keep…

2017年3月14日 · SM Mudda was one of the Jury Members for India Pharma Awards 2016. He shares his experience about the Jury Meet where they evaluated many Nomination entries ...

2017年5月24日 · Check out professional insights posted by S.M. Mudda, Managing Director at Misom Labs Limited, Malta; Chief Technical Advisor- Encube Ethicals, Mumbai; Chairman IDMA, Regulatory Affairs

https://lnkd.in/dEjT73rx | 63 comments on LinkedIn. Managing Director at Misom Labs Limited, Malta; Chief Technical Advisor- Encube Ethicals, Mumbai; Chairman IDMA, Regulatory Affairs

2024年2月26日 · The revised Schedule M of the Drugs and Cosmetics Rules is expected to bring Indian quality at par with global standards, according to SM Mudda of the Indian Drug Manufacturers' Association. The new guidelines, which deal with the good manufacturing practices to be followed by pharmaceutical manufacturing units, come amid complaints of sub ...